Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Genetic Services Laboratory University of Chicago United States | 72 | 133 |
|
Genetic Services Laboratory University of Chicago United States | 1 | 1 |
|
ASPM - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Invitae Brain Malformations Panel Invitae United States | 247 | 161 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Primary Microcephaly, Autosomal Recessive, via the ASPM Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Primary Microcephaly, Autosomal Recessive, Panel PreventionGenetics, part of Exact Sciences United States | 10 | 10 |
|
Fulgent Genetics United States | 354 | 209 |
|
Adolescent/Adult Epilepsy NGS Panel Fulgent Genetics United States | 182 | 82 |
|
Neuronal Migration Disorders NGS Panel Fulgent Genetics United States | 392 | 83 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics Inc United States | 233 | 234 |
|
Epilepsy Advanced Sequencing and CNV Evaluation - Developmental Brain Malformations Athena Diagnostics Inc United States | 43 | 40 |
|
Athena Diagnostics Inc United States | 80 | 84 |
|
Autosomal Recessive Primary Microcephaly Type 5 , Deletions-Duplications (MLPA) ASPM Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.